v3.26.1
REVERSE RECAPITALIZATION (Tables)
12 Months Ended
Dec. 31, 2025
REVERSE RECAPITALIZATION  
Schedule of reverse recapitalization

The following table reconciles the elements of the Business Combination to the consolidated statements of cash flows and the consolidated statements of changes in stockholders’ deficit for the year ended December 31, 2024:

Cash – MCAC’s trust and cash (net of redemption)

  ​ ​ ​

$

38,441,920

Less: transaction costs and advisory fees paid

(2,670,961)

Net Business Combination financing

$

35,770,959

The number of shares of the Company’s common stock issued immediately following the consummation of the Business Combination were:

Common stock, outstanding prior to Business Combination

  ​ ​ ​

121,837

Less: redemption of MCAC shares

(114,551)

Common stock of MCAC

7,286

MCAC founder shares

71,875

Rights issued to MCAC shareholders

28,750

Shares outstanding in connection with forward purchase agreement

101,515

Business Combination and forward purchase agreement financing shares

209,425

Legacy ConnectM shares

450,702

Total shares of common stock immediately after Business Combination

660,127

Issuance of shares of common stock after Business Combination

249,039

Total shares of common stock at December 31, 2024

909,165

  ​ ​ ​

  ​ ​ ​

Legacy

ConnectM

shares,

Legacy

effected for

ConnectM

Exchange

shares

Ratio

Recapitalization applied to common stock outstanding at December 31, 2022

1,588,141

164,831

Issuance of Old ConnectM shares prior to closing of Business Combination

5,000

519

Conversion of convertible notes payable to common stock prior to Business Combination

321,428

33,362

Recapitalization applied to Series Seed preferred stock outstanding at December 31, 2022

644,030

66,846

Recapitalization applied to Series Seed-1 preferred stock outstanding at December 31, 2022

91,120

9,458

Recapitalization applied to Series A-1 preferred stock outstanding at December 31, 2022

743,068

77,126

Recapitalization applied to Series B-1 preferred stock outstanding at December 31, 2022

649,843

67,449

Recapitalization applied to Series B-2 preferred stock outstanding at December 31, 2022

299,730

31,110

450,702